UK Markets close in 3 hrs 42 mins

Enanta Pharmaceuticals, Inc. (9EP.F)

Frankfurt - Frankfurt Delayed price. Currency in EUR
Add to watchlist
50.000.00 (0.00%)
As of 08:05AM CET. Market open.
Currency in EUR

Valuation measures4

We're sorry, we couldn't find any data.
Please try reloading the page.

Trading information

Stock price history

Beta (5Y monthly) 0.53
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 384.50
52-week low 334.00
50-day moving average 366.78
200-day moving average 350.92

Share statistics

Avg vol (3-month) 33
Avg vol (10-day) 39
Shares outstanding 520.32M
Implied shares outstanding 6N/A
Float 814.32M
% held by insiders 111.77%
% held by institutions 196.59%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Currency in USD.

Fiscal year

Fiscal year ends 30 Sept 2021
Most-recent quarter (mrq)30 Sept 2021

Profitability

Profit margin -81.38%
Operating margin (ttm)-112.88%

Management effectiveness

Return on assets (ttm)-14.81%
Return on equity (ttm)-18.48%

Income statement

Revenue (ttm)97.07M
Revenue per share (ttm)4.81
Quarterly revenue growth (yoy)-0.20%
Gross profit (ttm)97.07M
EBITDA -106.24M
Net income avi to common (ttm)-79M
Diluted EPS (ttm)-3.47
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)244M
Total cash per share (mrq)12.01
Total debt (mrq)6.83M
Total debt/equity (mrq)1.71
Current ratio (mrq)8.82
Book value per share (mrq)19.74

Cash flow statement

Operating cash flow (ttm)-70M
Levered free cash flow (ttm)-57.67M